Valneva to present on its chikungunya vaccine candidate and host a roundtable at the 23rd world vaccine congress in washington d.c.

Saint herblain (france), march 30, 2023 – valneva se (nasdaq: valn; euronext paris: vla), a specialty vaccine company, announced today it will present on its single-shot chikungunya vaccine candidate, vla1553, and host a roundtable on zika vaccines next week at the 23rd world vaccine congress in washington, d.c.
VALN Ratings Summary
VALN Quant Ranking